Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Prevalence and Type Distribution of Human Papillomavirus (HPV) in Tanzanian Men

This study has been completed.
Sponsor:
Collaborator:
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Susanne Kruger Kjaer, Danish Cancer Society
ClinicalTrials.gov Identifier:
NCT00932009
First received: June 30, 2009
Last updated: August 7, 2015
Last verified: August 2015